Cargando…

The social and economic disadvantage in pulmonary hypertension: A work (still) in progress

Detalles Bibliográficos
Autores principales:	Bernardo, Roberto J., de Jesus Perez, Vinicio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906002/ https://www.ncbi.nlm.nih.gov/pubmed/36788943 http://dx.doi.org/10.1002/pul2.12196

Ejemplares similares

Humidifier disinfectant: 78 deaths and still in progress
por: KIM, Yong Han
Publicado: (2013)

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
por: Piccari, Lucilla, et al.
Publicado: (2021)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021)

Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2010)

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up
por: Finsterer, Josef
Publicado: (2023)

Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up
por: Luani, Blerim, et al.
Publicado: (2023)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension and hemoglobinopathies
por: de Sousa, Ana Cecília Cardoso, et al.
Publicado: (2020)

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension
por: Agarwal, Stuti, et al.
Publicado: (2021)

Disadvantaged Groups and Mental Health Services, A Dilemma in Metropolitans
por: Ghadirian, Laleh, et al.
Publicado: (2020)

A case of adult-onset Still’s disease accompanied with pulmonary tuberculosis successfully treated with colchicine
por: Rao, Shijia, et al.
Publicado: (2021)

Maintaining Basic Social Ethics: Economic Man or Social Man?
por: Chen, Bingyuan, et al.
Publicado: (2022)

Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
por: Perez, Vinicio A. de Jesus, et al.
Publicado: (2012)

Chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2015)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Pulmonary capillary hemangiomatosis: an uncommon cause of pulmonary hypertension
por: Faria, Igor Murad, et al.
Publicado: (2013)

Westermark's and Palla's signs in acute and chronic pulmonary embolism: Still valid in the current computed tomography era
por: Brenes-Salazar, Jorge A.
Publicado: (2014)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Parental Attributions—Mothers’ Voices in Economically and Socially Disadvantaged Contexts
por: Narciso, Isabel, et al.
Publicado: (2022)

Editorial: Pulmonary Hypertension in the Modern Era: Science and Clinical Practice
por: Goncharova, Elena A., et al.
Publicado: (2021)

Prevalence of Hypertension among Working Adults in Rwanda
por: BANYANGIRIKI, Jacques, et al.
Publicado: (2013)

Halothane: I am still there
por: Bihani, Pooja, et al.
Publicado: (2016)

Acute Osteomyelitis: It is Still Here
por: Carrascosa, Miguel F, et al.
Publicado: (2017)

Are Our Hands Still Clean?
por: Bajaj, Ankur, et al.
Publicado: (2021)

Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers
por: Nawaytou, Hythem, et al.
Publicado: (2021)

We must not forget the most disadvantaged people facing the COVID-19 crisis
por: Mansuy, J.M., et al.
Publicado: (2020)

Should students still fear social media? Conveying an online personality can enrich the doctor–patient relationship
por: Mehta, Nitesh V., et al.
Publicado: (2014)

Reply: COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Lee, Joshua D., et al.
Publicado: (2021)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Encephalitis lethargica. What is still wrong?
por: Di Vito, A, et al.
Publicado: (2023)

Is the steth still mightier than the probe?
por: Sudhakar Rao, M.
Publicado: (2023)

Leprosy, Still Present in La Réunion
por: Vilain, Pascal, et al.
Publicado: (2012)

Fluoride carcinogenesis: The jury is still out!
por: Bajpai, Jyoti
Publicado: (2013)

Triclocarban and Health: the Jury Is Still Out
por: Kennedy, Rebekah C., et al.
Publicado: (2016)

Are we still living in NTP era?
por: Mehta, Jaykumar N.
Publicado: (2018)

Out of Sight, But Still Should Be in Mind
por: Smith, Kristin, et al.
Publicado: (2022)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II
por: Bogaard, Harm J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npo3jpk1m2flb4d0en68buv3pg